bromopyruvate has been researched along with Colorectal Cancer in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Alboghobeish, S; Behmanesh, B; Khodayar, MJ; Mahdavinia, M; Nikravesh, H; Teimoori, A; Zeidooni, L | 1 |
Chong, D; Huo, Q; Liu, F; Liu, H; Ma, L; Zhang, P; Zhang, Z; Zhao, S; Zheng, H | 1 |
Azevedo-Silva, J; Baltazar, F; Casal, M; Côrte-Real, M; Ferro, S; Preto, A | 1 |
Azevedo-Silva, J; Casal, M; Pereira-Vieira, J; Preto, A; Queirós, O | 1 |
Coomber, BL; Ho, N; Morrison, J; Silva, A | 1 |
Angenendt, P; Cheong, I; Diaz, LA; Kinzler, KW; Lengauer, C; Markowitz, S; Pagliarini, R; Papadopoulos, N; Rago, C; Rajagopalan, H; Schmidt, K; Velculescu, VE; Vogelstein, B; Willson, JK; Yun, J; Zhou, S | 1 |
Hu, Y; Huang, P; Tang, Z; Wu, W; Xu, R; Yang, J; Yuan, S; Yun, J; Zeng, Z; Zhang, H | 1 |
7 other study(ies) available for bromopyruvate and Colorectal Cancer
Article | Year |
---|---|
The combined effect of dichloroacetate and 3-bromopyruvate on glucose metabolism in colorectal cancer cell line, HT-29; the mitochondrial pathway apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Dichloroacetic Acid; Drug Synergism; Fluorouracil; Glucose; HT29 Cells; Humans; Membrane Potential, Mitochondrial; Metabolic Networks and Pathways; Mitochondria; Models, Biological; Pyruvates | 2021 |
Synergistic antitumor effect of 3-bromopyruvate and 5-fluorouracil against human colorectal cancer through cell cycle arrest and induction of apoptosis.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Colorectal Neoplasms; Drug Synergism; Female; Fluorouracil; HT29 Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Pyruvates; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2017 |
Characterization of acetate transport in colorectal cancer cells and potential therapeutic implications.
Topics: Acetates; Biological Transport; Cell Line, Tumor; Colorectal Neoplasms; Glycolysis; Humans; Monocarboxylic Acid Transporters; Muscle Proteins; Pyruvates; Symporters | 2016 |
MCT1, MCT4 and CD147 expression and 3-bromopyruvate toxicity in colorectal cancer cells are modulated by the extracellular conditions.
Topics: Antineoplastic Agents; Basigin; Cell Hypoxia; Cell Line, Tumor; Colorectal Neoplasms; Glucose; Glycolysis; Humans; Hydrogen-Ion Concentration; Monocarboxylic Acid Transporters; Muscle Proteins; Oxygen; Pyruvate Dehydrogenase Complex; Pyruvates; Symporters | 2019 |
The effect of 3-bromopyruvate on human colorectal cancer cells is dependent on glucose concentration but not hexokinase II expression.
Topics: Apoptosis; Cell Line, Tumor; Colorectal Neoplasms; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glucose; Hexokinase; Humans; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyruvates | 2016 |
Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Gene Expression Regulation, Neoplastic; Gene Targeting; Genes, ras; Glucose; Glucose Transporter Type 1; Glycolysis; Humans; Lactic Acid; Mice; Mice, Nude; Mutation; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Proto-Oncogene Proteins B-raf; Pyruvates; Transplantation, Heterologous | 2009 |
Over-expression of GAPDH in human colorectal carcinoma as a preferred target of 3-bromopyruvate propyl ester.
Topics: Adenosine Triphosphate; Apoptosis; Blotting, Western; Cell Proliferation; Colorectal Neoplasms; Flow Cytometry; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glyceraldehyde-3-Phosphate Dehydrogenases; Hexokinase; Humans; Immunohistochemistry; Liver Neoplasms; Pyruvates | 2012 |